Trademark: 98298243
Word
REVOLUTION MEDICINES
Status
Pending
Status Code
686
Status Date
Tuesday, June 18, 2024
Serial Number
98298243
Mark Type
3
Filing Date
Monday, December 4, 2023
Published for Opposition
Tuesday, June 18, 2024

Trademark Owner History
Revolution Medicines, Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for the treatment of oncological and immune system related diseases and disorders
44 Providing medical information via a website; providing health information via a website; providing information to patients and healthcare professionals via a website relating to disease diagnosis, management, and treatment options in the field of oncological and immune system related diseases and disorders
42 Pharmaceutical research and development; drug discovery services; providing information about medical and scientific research
The mark consists of a hexagonal design to the left of the word REVOLUTION over the word MEDICINES.
Color is not claimed as a feature of the mark.
"MEDICINES"

Trademark Events
Dec 4, 2023
New Application Entered
Feb 28, 2024
Notice Of Design Search Code E-Mailed
Feb 28, 2024
New Application Office Supplied Data Entered
Mar 4, 2024
Use Amendment Filed
Mar 4, 2024
Amendment To Use Processing Complete
Mar 4, 2024
Teas Amendment Of Use Received
May 9, 2024
Assigned To Examiner
May 9, 2024
Assigned To Examiner
May 15, 2024
Examiners Amendment -Written
May 15, 2024
Examiners Amendment E-Mailed
May 15, 2024
Examiners Amendment -Written
May 15, 2024
Notification Of Examiners Amendment E-Mailed
May 15, 2024
Examiner's Amendment Entered
May 15, 2024
Examiners Amendment E-Mailed
May 15, 2024
Examiner's Amendment Entered
May 15, 2024
Notification Of Examiners Amendment E-Mailed
May 16, 2024
Approved For Pub - Principal Register
May 29, 2024
Notification Of Notice Of Publication E-Mailed
Jun 18, 2024
Published For Opposition
Jun 18, 2024
Official Gazette Publication Confirmation E-Mailed
May 11, 2024
Notice Of Acceptance Of Amendment To Allege Use E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24